Source:http://linkedlifedata.com/resource/pubmed/id/21474568
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2011-6-23
|
pubmed:abstractText |
The abuse liability profile of three synthetic hallucinogens, N,N-diisopropyltryptamine (DIPT), 5-N,N-diethyl-5-methoxytryptamine (5-MeO-DET), and 5-methoxy-?-methyltryptamine (5-MeO-AMT), was tested in rats trained to discriminate hallucinogenic and psychostimulant compounds, including cocaine, methamphetamine, 3,4-methylenedioxymethylamphetamine (MDMA), lysergic acid diethylamide (LSD), (-)-2,5-dimethoxy-4-methylamphetamine (DOM), and dimethyltryptamine (DMT). Because abused hallucinogens act at 5-hydroxytryptamine 1A (5-HT(1A)) and 5-HT(2A) receptors, and abused psychostimulants act at monoamine transporters, binding and functional activities of DIPT, 5-MeO-DET, and 5-MeO-AMT at these sites were also tested. DIPT fully substituted in rats trained to discriminate DMT (ED(50) = 1.71 mg/kg) and DOM (ED(50) = 1.94 mg/kg), but produced only 68% LSD-appropriate responding. 5-MeO-DET fully substituted for DMT (ED(50) = 0.41 mg/kg) and produced 59% MDMA-appropriate responding. 5-MeO-AMT did not fully substitute for any of the training drugs, but produced 67% LSD-appropriate responding. None of the compounds produced substitution in rats trained to discriminate cocaine or methamphetamine. All three compounds showed activity at 5-HT(1A) and 5-HT(2A) receptors as well as blockade of reuptake by the serotonin transporter. In addition, 5-MeO-AMT produced low levels of serotonin release and low potency blockade of dopamine uptake. DIPT, 5-MeO-DET, and 5-MeO-AMT produced behavioral and receptor effects similar to those of abused hallucinogens, but were not similar to those of psychostimulants. DIPT and 5-MeO-DET may have abuse liability similar to known hallucinogens and may be hazardous because high doses produced activity and lethality.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/5-methoxy-alpha-methyltryptamine,
http://linkedlifedata.com/resource/pubmed/chemical/Hallucinogens,
http://linkedlifedata.com/resource/pubmed/chemical/N,N-diisopropyltryptamine,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Serotonin, 5-HT1A,
http://linkedlifedata.com/resource/pubmed/chemical/Serotonin,
http://linkedlifedata.com/resource/pubmed/chemical/Tryptamines
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1521-0103
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
338
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
280-9
|
pubmed:meshHeading |
pubmed-meshheading:21474568-Animals,
pubmed-meshheading:21474568-Discrimination Learning,
pubmed-meshheading:21474568-HEK293 Cells,
pubmed-meshheading:21474568-Hallucinogens,
pubmed-meshheading:21474568-Humans,
pubmed-meshheading:21474568-Male,
pubmed-meshheading:21474568-Mice,
pubmed-meshheading:21474568-Motor Activity,
pubmed-meshheading:21474568-Protein Binding,
pubmed-meshheading:21474568-Rats,
pubmed-meshheading:21474568-Rats, Sprague-Dawley,
pubmed-meshheading:21474568-Receptor, Serotonin, 5-HT1A,
pubmed-meshheading:21474568-Serotonin,
pubmed-meshheading:21474568-Substance-Related Disorders,
pubmed-meshheading:21474568-Tryptamines
|
pubmed:year |
2011
|
pubmed:articleTitle |
Abuse liability profile of three substituted tryptamines.
|
pubmed:affiliation |
Pharmacology and Neuroscience, University of North Texas Health Science Center, Fort Worth, Texas 76107-2699, USA. michael.gatch@unthsc.edu
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, U.S. Gov't, Non-P.H.S.,
Research Support, N.I.H., Extramural
|